Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study.
Costa-Frossard França L, Meca Lallana V, Labiano-Fontcuberta A, Blasco R, Monreal E, Martínez Ginés ML, Aguirre C, Sabin Muñoz J, Sainz de la Maza S, Cuello JP, Díaz-Pérez C, Chico García JL, Lozano Ros A, Rodríguez Jorge F, Martínez Martínez S, García Domínguez JM.
Costa-Frossard França L, et al. Among authors: martinez martinez s.
CNS Drugs. 2024 Mar;38(3):231-238. doi: 10.1007/s40263-024-01066-3. Epub 2024 Feb 28.
CNS Drugs. 2024.
PMID: 38418770
Free PMC article.